|
1
|
Lv Y, Song L, Chang L, Liu Y, Zhang X,
Wang Y, Wang L and Liu W: Bevacizumab followed by chemotherapy is
potential therapy for gastric cancer. J BUON. 21:1466–1470.
2016.PubMed/NCBI
|
|
2
|
Shu B, Lei S, Li F, Hua S, Chen Y and Huo
Z: Laparoscopic total gastrectomy compared with open resection for
gastric carcinoma: A case-matched study with long-term follow-up. J
BUON. 21:101–107. 2016.PubMed/NCBI
|
|
3
|
Shen YH, Xie ZB, Yue AM, Wei QD, Zhao HF,
Yin HD, Mai W, Zhong XG and Huang SR: Expression level of
microRNA-195 in the serum of patients with gastric cancer and its
relationship with the clinicopathological staging of the cancer.
Eur Rev Med Pharmacol Sci. 20:1283–1287. 2016.PubMed/NCBI
|
|
4
|
Zhou SF, Yin JB, Yang H, Zhong J and An P:
Application value of stomach filling ultrasonography and
intravenous contrast agents in diagnosis of advanced gastric
cancer. Eur Rev Med Pharmacol Sci. 20:3206–3210. 2016.PubMed/NCBI
|
|
5
|
Zhang N, Wang AY, Wang XK, Sun XM and Xue
HZ: GAS5 is downregulated in gastric cancer cells by promoter
hypermethylation and regulates adriamycin sensitivity. Eur Rev Med
Pharmacol Sci. 20:3199–3205. 2016.PubMed/NCBI
|
|
6
|
Mello BS, Lucena AF, Echer IC and Luzia
MF: Patients with gastric cancer submitted to gastrectomy: An
integrative review. Rev Gaúcha Enferm. 31:803–811. 2010.(In
Portuguese). View Article : Google Scholar
|
|
7
|
Bang YJ, van Cutsem E, Feyereislova A,
Chung HC, Shen L, Sawaki A, Lordick F, Ohtsu A, Omuro Y, Satoh T,
et al: ToGA Trial Investigators: Trastuzumab in combination with
chemotherapy versus chemotherapy alone for treatment of
HER2-positive advanced gastric or gastro-oesophageal junction
cancer (ToGA): A phase 3, open-label, randomised controlled trial.
Lancet. 376:687–697. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Olaku O and White JD: Herbal therapy use
by cancer patients: A literature review on case reports. Eur J
Cancer. 47:508–514. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Aggarwal BB, Bhardwaj A, Aggarwal RS,
Seeram NP, Shishodia S and Takada Y: Role of resveratrol in
prevention and therapy of cancer: Preclinical and clinical studies.
Anticancer Res. 24:2783–2840. 2004.PubMed/NCBI
|
|
10
|
Gescher A, Steward WP and Brown K:
Resveratrol in the management of human cancer: How strong is the
clinical evidence? Ann N Y Acad Sci. 1290:12–20. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Crew KD and Neugut AI: Epidemiology of
upper gastrointestinal malignancies. Semin Oncol. 31:450–464. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Miyoshi K and Hennighausen L:
Beta-catenin: A transforming actor on many stages. Breast Cancer
Res. 5:63–68. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Maruyama K, Ochiai A, Akimoto S, Nakamura
S, Baba S, Moriya Y and Hirohashi S: Cytoplasmic beta-catenin
accumulation as a predictor of hematogenous metastasis in human
colorectal cancer. Oncology. 59:302–309. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Polakis P: Wnt signaling and cancer. Genes
Dev. 14:1837–1851. 2000.PubMed/NCBI
|
|
15
|
Lim SC and Lee MS: Significance of
E-cadherin/β-catenin complex and cyclin D1 in breast cancer. Oncol
Rep. 9:915–928. 2002.PubMed/NCBI
|
|
16
|
Roh MS, Hong SH, Jeong JS, Kwon HC, Kim
MC, Cho SH, Yoon JH and Hwang TH: Gene expression profiling of
breast cancers with emphasis of beta-catenin regulation. J Korean
Med Sci. 19:275–282. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Utsuki S, Sato Y, Oka H, Tsuchiya B,
Suzuki S and Fujii K: Relationship between the expression of E-,
N-cadherins and beta-catenin and tumor grade in astrocytomas. J
Neurooncol. 57:187–192. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ehrlich D, Bruder E, Thome MA, Gutt CN,
von Knebel Doeberitz M, Niggli F, Perantoni AO and Koesters R:
Nuclear accumulation of beta-catenin protein indicates activation
of wnt signaling in chemically induced rat nephroblastomas. Pediatr
Dev Pathol. 13:1–8. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hu Y, Wang S, Wu X, Zhang J, Chen R, Chen
M and Wang Y: Chinese herbal medicine-derived compounds for cancer
therapy: A focus on hepatocellular carcinoma. J Ethnopharmacol.
149:601–612. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu YZ, Wu K, Huang J, Liu Y, Wang X, Meng
ZJ, Yuan SX, Wang DX, Luo JY, Zuo GW, et al: The PTEN/PI3K/Akt and
Wnt/β-catenin signaling pathways are involved in the inhibitory
effect of resveratrol on human colon cancer cell proliferation. Int
J Oncol. 45:104–112. 2014. View Article : Google Scholar : PubMed/NCBI
|
